{'fraction_non_alphanumeric': 0.047304730473047306, 'fraction_numerical': 0.045104510451045104, 'mean_word_length': 4.723270440251572, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Costimulatory molecules (CD80 and CD86) on Reed‐Sternberg cells are associated with the proliferation of background T cells in Hodgkin's disease

To elucidate the relationship between Reed‐Sternberg (R‐S) cells and background T cells, the expression of CD80 and CD86 of R‐S cells in Hodgkin's disease (HD), and the ligand CD28 expression and the MIB‐1 index of background T cells were immunohistochemically investigated. CD80 and CD86 were found to be expressed on R‐S cells in almost all cases of HD. CD28 was expressed with strong intensity on many background T cells around R‐S cells. The MIB‐1 index of background T cells was 30.3% (range, 15.5–38.9%) and was much higher than 10.9% (range, 9.8–11.7%) in B cell lymphomas. These results suggest that the interaction between CD80 and CD86 on R‐S cells, and CD28 on background T cells may induce T cell proliferation and be associated with tumor mass of HD.